These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19090748)

  • 1. Characterizing antibody specificity to different protein morphologies by AFM.
    Wang MS; Zameer A; Emadi S; Sierks MR
    Langmuir; 2009 Jan; 25(2):912-8. PubMed ID: 19090748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
    Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
    Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies.
    Barkhordarian H; Emadi S; Schulz P; Sierks MR
    Protein Eng Des Sel; 2006 Nov; 19(11):497-502. PubMed ID: 16984950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human alpha-synuclein specific single chain antibodies.
    Maguire-Zeiss KA; Wang CI; Yehling E; Sullivan MA; Short DW; Su X; Gouzer G; Henricksen LA; Wuertzer CA; Federoff HJ
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1198-205. PubMed ID: 16973126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.
    Emadi S; Barkhordarian H; Wang MS; Schulz P; Sierks MR
    J Mol Biol; 2007 May; 368(4):1132-44. PubMed ID: 17391701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-molecule selection and recovery of structure-specific antibodies using atomic force microscopy.
    Shlyakhtenko LS; Yuan B; Emadi S; Lyubchenko YL; Sierks MR
    Nanomedicine; 2007 Sep; 3(3):192-7. PubMed ID: 17662669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein interactions and misfolding analyzed by AFM force spectroscopy.
    McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
    J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells.
    Zameer A; Kasturirangan S; Emadi S; Nimmagadda SV; Sierks MR
    J Mol Biol; 2008 Dec; 384(4):917-28. PubMed ID: 18929576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers.
    van Rooijen BD; van Leijenhorst-Groener KA; Claessens MM; Subramaniam V
    J Mol Biol; 2009 Dec; 394(5):826-33. PubMed ID: 19837084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
    Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
    Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of alpha-synuclein fibrils in nanoscale studied by peptide truncation and AFM.
    Zhang F; Lin XJ; Ji LN; Du HN; Tang L; He JH; Hu J; Hu HY
    Biochem Biophys Res Commun; 2008 Apr; 368(2):388-94. PubMed ID: 18230346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helical alpha-synuclein forms highly conductive ion channels.
    Zakharov SD; Hulleman JD; Dutseva EA; Antonenko YN; Rochet JC; Cramer WA
    Biochemistry; 2007 Dec; 46(50):14369-79. PubMed ID: 18031063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Aβ aggregation state by atomic force microscopy.
    Legleiter J
    Methods Mol Biol; 2011; 670():57-70. PubMed ID: 20967583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates.
    Nannenga BL; Zameer A; Sierks MR
    FEBS Lett; 2008 Feb; 582(4):517-22. PubMed ID: 18230361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing.
    van Rooijen BD; Claessens MM; Subramaniam V
    FEBS Lett; 2008 Nov; 582(27):3788-92. PubMed ID: 18930058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells.
    Yuan B; Sierks MR
    Neurosci Lett; 2009 Jul; 459(1):16-8. PubMed ID: 19394405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS; Caarls W; Demchenko AP; Jovin TM
    Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
    Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.